Analyst firms · Jefferies · CRL
Jefferies CRL price target and rating history
Charles River Laboratories International Inc. (CRL) · Health Care
Jefferies rates Charles River Laboratories International Inc. (CRL) Buy with a $195 price target, as of its latest action on Sep 9, 2025. It has published 4 rating actions on CRL since April 2022, including 2 upgrades and 2 downgrades. Across 5 firms with a CRL price target in the last 12 months, the median target is $220.
- Current rating
- Buy
- Price target
- $195
- Median target, all firms
- $220
- Actions on CRL
- 4
Jefferies price target on CRL
Every Jefferies rating on CRL
- Sep 9, 2025
- Jan 12, 2023
- Sep 30, 2022
- Apr 25, 2022
How other firms rate CRL
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Buy | $357 | Sep 30, 2026 |
| CLSA | Hold | $219 | Jul 20, 2026 |
| Morgan Stanley | Overweight | $220 | Jun 17, 2026 |
| RBC Capital Markets | Outperform | $215 | Apr 14, 2026 |
| BofA Securities | Buy | $225 | Dec 15, 2025 |
| Argus Research | Buy | Nov 17, 2025 |
Questions about Jefferies and CRL
- What is Jefferies's price target for CRL?
- Jefferies's latest stated price target for Charles River Laboratories International Inc. (CRL) is $195, from its action on Sep 9, 2025.
- What is Jefferies's rating on CRL?
- Jefferies rates CRL Buy, a bullish rating, as of Sep 9, 2025.
- When did Jefferies last change its view on CRL?
- On Sep 9, 2025, Jefferies upgrades to Buy from Hold, price target $195.
- How does Jefferies's CRL target compare with other analysts?
- Across 5 firms with a CRL price target in the last 12 months, the median target is $220.
More CRL rating histories
All Jefferies ratingsCRL news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.